STK11, mutated or deleted in a third of non-small-cell lung cancer patients, fosters an immunologically “cold” tumor microenvironment, with minimal penetration of tumors by T cells, rendering anti-PD1/PDL1 drugs ineffective [36]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.